Background: Observational studies have associated obstructive sleep apnea (OSA) with a higher risk of various cancers; however, causal relationships have not yet been definitively established.Methods: Our study evaluated the causal impact of OSA on the risk of developing 22 different types of cancer using univariable and multivariable Mendelian randomization (MR). OSA‐associated genetic instruments were obtained from the FinnGen study, which incorporates 38,998 OSA individuals and 336,659 non‐OSA individuals from European descent. Summary‐level data for 22 site‐specific cancers were estimated from large genetic consortia and UK Biobank. We used inverse‐variance weighting (IVW) as the primary analysis, along with several sensitivity analyses.Results: Univariable MR analyses indicated a causal relationship of genetic susceptibility to OSA on an increased risk of Barrett's esophagus (BE) and esophageal cancer (odds ratio [OR] = 1.32, 95% confidence interval [CI] = 1.07−1.62, p = 0.01), endometrial cancer (OR = 1.36, 95% CI = 1.16−1.60, p = 2.26E‐04), and its endometrioid subtype (OR = 1.28, 95% CI = 1.04−1.59, p = 0.02). Multivariable MR, accounting for possible confounders like drinking and smoking, confirmed the causal relationships of OSA on BE and esophageal cancer, and endometrial cancer.Conclusions: This study provided evidence regarding causal associations of OSA with higher risk of BE and esophageal cancer, and endometrial cancer.
Background. Limited and controversial evidence is available on the efficacy of surgery for patients with stage I primary parotid gland lymphoma. Thus, we aimed to investigate whether surgery can enhance the prognosis of patients with stage I primary parotid gland lymphoma using large sample data. Methods. From 1998 to 2015, we searched the Surveillance, Epidemiology, and End Results (SEER) program database and extracted information regarding patients with stage I primary parotid gland lymphoma; we classified these patients into surgery and nonsurgery groups. We calculated overall survival (OS) and cancer-specific survival (CSS) using Kaplan–Meier curves and log-rank testing. Propensity score matching (PSM) analysis was also used to further account for confounding variables before comparing the OS and CSS again. We used the COX proportional hazard regression model in both multivariate and univariate analyses. Results. We enrolled 918 patients with stage I primary parotid gland lymphoma, among which 656 (71.5%) patients underwent surgery. Before PSM, the surgery group had better OS (hazard ratio (HR) = 0.673, 95% confidence interval (CI): 0.519–0.873, and ) and CSS (HR = 0.595, 95% CI: 0.403–0.879, and ) than the nonsurgery group. After PSM, surgery was still a beneficial factor for OS (HR = 0.569, 95% CI: 0.399–0.810, and ) and CSS (HR = 0.384, 95% CI: 0.220–0.669, and ). Furthermore, in univariate and multivariate analyses, total parotidectomy significantly increased OS ( and , respectively) and CSS ( and , respectively). Conclusions. In summary, the prognosis of patients with stage I primary parotid gland lymphoma can be significantly improved by surgery. Moreover, total parotidectomy was a protective factor for OS and CSS before and after PSM analysis, suggesting that surgery acts as a significant component in multimodal therapy for early primary parotid gland lymphoma.